1 ) von Herbay A‚ Illes A‚ Waldherr R‚ et al: Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer‚ 66: 587-592‚ 1990.
2 ) Sato Y‚ Marutsuka K‚ Asada Y‚ et al: Pulmonary tumor thrombotic microangiopathy. Pathol Int‚ 45: 436-440‚ 1995.
3 ) Uruga H‚ Fujii T‚ Kurosaki A‚ et al: Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med‚ 52: 1317-1323‚ 2013.
4 ) Chinen K‚ Fujino T‚ Horita A‚ et al: Pulmonary tumor thrombotic microangiopathy caused by an ovarian cancer expressing tissue factor and vascular endothelial growth factor. Pathol Res Pract‚ 205: 63-68‚ 2009.
5 ) Sakashita N‚ Yokose C‚ Fujii K‚ et al: Pulmonary tumor thrombotic microangiopathy resulting from metastatic signet ring cell carcinoma of the stomach. Pathol Int‚ 57: 383-387‚ 2007.
6 ) Takahashi F‚ Kumasaka T‚ Nagaoka T‚ et al: Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma. Pathol Int‚ 59: 752-756‚ 2009.
7 ) Hara A‚ Ichinoe M‚ Ogawa T‚ et al: A microscopic adenocarcinoma of the stomach with pulmonary tumor thrombotic microangiopathy in a 17-year-old male. Pathol Res Pract‚ 201: 457-461‚ 2005.
8 ) Miyano S‚ Izumi S‚ Takeda Y‚ et al: Pulmonary tumor thrombotic microangiopathy. J Clin Oncol‚ 25: 597-599‚ 2007.
9 ) Pentheroudakis G‚ Golfinopoulos V‚ Pavlidis N: Switching benchmarks in cancer of unknown primary: from autopsy to microarray. Eur J Cancer‚ 43: 2026-2036‚ 2007.
10) Keenan NG‚ Nicholson AG‚ Oldershaw PJ: Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy. Int J Cardiol‚ 124: e11-e13‚ 2008.